Magnetic Isolation of the Linear Trinuclear Anion in [Cu(Him)(6)] {Cu(Him)(4)[Cu(μ-EDTA)(Him)](2)}·6H(2)O (1) as the Novel Imidazolium(+) Salt (H(2)im)(2)[Cu(Him)(4){(µ-EDTA)Cu(Him)}(2)]·2H(2)O (2)-A Comparative Look to Their Crystal Structures, Thermal, Spectral and Magnetic Properties and DFT Calculations

[Cu(Him)6]{Cu(Him)4[Cu(μ-EDTA)(Him)]2}·6H2O (1) 中线性三核阴离子的磁隔离及其作为新型咪唑鎓(+)盐(H2im)2[Cu(Him)4{(μ-EDTA)Cu(Him)}2]·2H2O (2)——晶体结构、热学、光谱学和磁学性质及DFT计算的比较研究

阅读:1

Abstract

Inspired by the reported crystal structure of compound 1, we aimed to synthesize and determine the structure of compound 2, where two imidazolium (H(2)im(+)) ions serve as diamagnetic countercations. Here, we report the thermal stabilities, FT-IR, visible, and RSE spectra, as well as the magnetic properties of both compounds. In these structures, µ-EDTA acts as a pentadentate chelator for both terminal Cu centers within the centrosymmetric linear trinuclear anion. The Cu(µ-EDTA) chelates bind to the central Cu(Him)(4) unit in subtly different ways: in compound 1, µ-EDTA has a free acetate arm and binds the central Cu(II) center through a syn,anti-carboxylate group. In contrast, in compound 2, the non-chelating acetate arm serves as a monodentate O-donor to the central Cu(II) atom, increasing the Cu(terminal)···Cu(central) distance from 6.08 Å in 1 to 6.80 Å in 2. Additionally, pairs of H(2)im(+) ions in compound 2 display antiparallel π-stacking interactions. We conclude that the H(2)im(+) counterions in compound 2 enable the magnetic isolation of the nearly identical trinuclear anion present in both compounds. DFT calculations further support the role of different interactions in stabilizing each crystal structure. In compound 2, dominant contributions from N-H···O hydrogen bonds and π-stacking interactions are accompanied by other, less conventional interactions, such as multiple C-H···O contacts and an O···CO(π-hole) interaction within the trinuclear anion.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。